1.  Are you an EPIC site and using or considered using  the auto verification functionality? 

2.  If you are using auto verification, where do you use it e.g.. PACU, ER etc.?

3.  If you are not NOT using auto verification can you tell me how long it takes for a pharmacist to verify orders in PACU or ER?  Will the nurses override if the pharmacist verification is slow?

Thanks.  Tom

Does anyone have guidance on pharmacy loading of chemoembolization beads for interventional radiology. Is the contrast added by the pharmacy staff or radiology? What measures are taken to not transfer a hazardous substance to a sterile syringe outside of a hood (done in the procedure by the doc)?

Do you monitor Pyxis overrides as a safety metric?  What is your target/standard?  Thanks

We implemented bedside barcode scanning of medications prior to administration about a year ago. Do you have a policy or procedure for the scanning when a nurse obtains the medication for a physician and then administers it at the bedside? Is it a written policy or just "understood"?

Thanks in advance for your response.

Donna Fine

Hello everyone,

We are close to depleting our supply of phentolamine. What alternatives are you providing for your medical staff?

Are you having the phentolamine compounded?

For those using nitroglycerin ointment - have you seen good case reports with use?

What concentration(s) of methadone oral solution do you carry in your inventory?

We currently have both 1mg/mL and 10mg/mL and had a near miss.

thanks

Susan

We recently converted to Pyxis ES cabinets and use them as our primary drug distribution process. We have both cubies and open matrix drawers. When a new medication is restocked there is a safety concern not to place similar meds next to each other. When the techs are busy it is easy to simply restock the med in the next available open pocket that Pyxis displays. Can you share your ideas on how to reduce errors. Thanks. Tom
 

Recently I have come across several defective Calcium Chloride 10% prefilled syringes with  possible manufacturer errors. These syringes were manufacturered by Agila Pharmaceuticals and distributed by Amneal Pharmaceuticals.

Do you have policies or procedures in place (for pharmacy, physicians, or the system) to discontinue inactive drips on a patient’s profile?